Delivery Order SPE2DB25D3008-SPE2DB25FRDKY
- Not listed
- The Defense Logistics Agency awarded a $15.9K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a firm fixed price structure and an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,756.32 firm fixed price delivery order for TUKYSA 150 MG tablets (120 count units) on August 18, 2025, with completion scheduled for September 9, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,395.38 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (120-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price contract was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TUKYSA 150 mg tablets in quantities of 120 units. This competitive, non-set-aside delivery order is valued at $50,790.76 with a firm fixed price and is scheduled for completion by October 20, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12,697.69 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TUKYSA 150 mg tablets (120 count) with a completion date of October 15, 2025. This competitively awarded, firm fixed-price contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $6,306.64 to AmerisourceBergen Drug Corp for the supply of TUKYSA 50 mg tablets (60-count units) with a firm fixed price structure. This competitively awarded, non-set-aside contract is scheduled for completion by October 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $15,756.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a prescription oncology medication. This delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDKYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,756.32 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (120-count units) under a firm fixed-price contract type. The award was made on September 26, 2025, with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract supports critical military medical operations by providing specialty medications, brand-name and generic drugs, and other pharmaceutical commodities to authorized customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 9/26/25 |